Analysis of the Serum Marker EPCA-2 in Prostate Cancer

$252,580P50FY2008CANIH

Johns Hopkins University, Baltimore MD

Investigators

Robert Getzenbergcontact

Linked publications & trials

Paper 39578659 Paper 39483900 Paper 39314954 Paper 39269310 Paper 39229204 Paper 39198404 Paper 39040171 Paper 38645078 Paper 38388857 Paper 38112617 Paper 38050147 Paper 37907729 Paper 37850574 Paper 37849074 Paper 37661807 Paper 37409952 Paper 37347938 Paper 37066381 Paper 37012549 Paper 36821396 Paper 36373171 Paper 36372998 Paper 36337169 Paper 36309102 Paper 36194476 Paper 36006048 Paper 35938545 Paper 35908379 Paper 35836303 Paper 35452513 Paper 35333400 Paper 35188986 Paper 35131885 Paper 35104804 Paper 34969655 Paper 34652816 Paper 34533610 Paper 34431104 Paper 34402095 Paper 34341114 Paper 34191807 Paper 34145040 Paper 34062284 Paper 34019793 Paper 33949714 Paper 33724955 Paper 33617332 Paper 33564617 Paper 33511883 Paper 33462368 Paper 33355185 Paper 33328650 Paper 33148676 Paper 33148078 Paper 33024700 Paper 32989253 Paper 32740981 Paper 32723566 Paper 32694154 Paper 32649013 Paper 32587951 Paper 32581009 Paper 32525914 Paper 32506665 Paper 32468444 Paper 32389660 Paper 32304697 Paper 32182119 Paper 32173650 Paper 32031685 Paper 32015231 Paper 31969336 Paper 31915143 Paper 31650100 Paper 31524299 Paper 31503450 Paper 31499027 Paper 31489119 Paper 31361358 Paper 31277779 Paper 31105884 Paper 30775254 Paper 30775253 Paper 30775245 Paper 30735000 Paper 30691685 Paper 30655600 Paper 30636012 Paper 30518666 Paper 30518628 Paper 30488530 Paper 30291220 Paper 30242839 Paper 30214054 Paper 30082453 Paper 30070053 Paper 29959132 Paper 29934341 Paper 29851094 Paper 29849114

View original record on NIH RePORTER →